These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38234913)

  • 1. Tackling the implementation gap for the uptake of NGS and advanced molecular diagnostics into healthcare systems.
    Horgan D; Van den Bulcke M; Malapelle U; Troncone G; Normanno N; Capoluongo ED; Prelaj A; Rizzari C; Trapani D; Singh J; Kozaric M; Longshore J; Ottaviano M; Boccia S; Pravettoni G; Cattaneo I; Malats N; Buettner R; Lekadir K; de Lorenzo F; Hofman P; De Maria R
    Heliyon; 2024 Jan; 10(1):e23914. PubMed ID: 38234913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Framework for Adoption of Next-Generation Sequencing (NGS) Globally in the Oncology Area.
    Horgan D; Hamdi Y; Lal JA; Nyawira T; Meyer S; Kondji D; Francisco NM; De Guzman R; Paul A; Bernard B; Reddy Nallamalla K; Park WY; Triapthi V; Tripathi R; Johns A; Singh MP; Phipps ME; Dube F; Rasheed HMA; Kozaric M; Pinto JA; Doral Stefani S; Aponte Rueda ME; Fujita Alarcon R; Barrera-Saldana HA
    Healthcare (Basel); 2023 Feb; 11(3):. PubMed ID: 36767006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe.
    Horgan D; Curigliano G; Rieß O; Hofman P; Büttner R; Conte P; Cufer T; Gallagher WM; Georges N; Kerr K; Penault-Llorca F; Mastris K; Pinto C; Van Meerbeeck J; Munzone E; Thomas M; Ujupan S; Vainer GW; Velthaus JL; André F
    J Pers Med; 2022 Jan; 12(1):. PubMed ID: 35055387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fighting Cancer around the World: A Framework for Action.
    Horgan D; Mia R; Erhabor T; Hamdi Y; Dandara C; Lal JA; Fokom Domgue J; Ewumi O; Nyawira T; Meyer S; Kondji D; Francisco NM; Ikeda S; Chuah C; De Guzman R; Paul A; Reddy Nallamalla K; Park WY; Tripathi V; Tripathi R; Johns A; Singh MP; Phipps ME; Dube F; Whittaker K; Mukherji D; Rasheed HMA; Kozaric M; Pinto JA; Doral Stefani S; Augustovski F; Aponte Rueda ME; Fujita Alarcon R; Barrera-Saldana HA
    Healthcare (Basel); 2022 Oct; 10(11):. PubMed ID: 36360466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer patient management: Current use of next-generation sequencing in the EU TOP4.
    Hedblom AH; Pruneri G; Quagliata L; Costa JL; Dumanois R; Rolando C; Saunders R
    J Cancer Policy; 2023 Mar; 35():100376. PubMed ID: 36511325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerating the Development and Validation of Liquid Biopsy for Early Cancer Screening and Treatment Tailoring.
    Horgan D; Čufer T; Gatto F; Lugowska I; Verbanac D; Carvalho Â; Lal JA; Kozaric M; Toomey S; Ivanov HY; Longshore J; Malapelle U; Hasenleithner S; Hofman P; Alix-Panabières C
    Healthcare (Basel); 2022 Sep; 10(9):. PubMed ID: 36141326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers to clinical adoption of next generation sequencing: Perspectives of a policy Delphi panel.
    Messner DA; Al Naber J; Koay P; Cook-Deegan R; Majumder M; Javitt G; Deverka P; Dvoskin R; Bollinger J; Curnutte M; Chandrasekharan S; McGuire A
    Appl Transl Genom; 2016 Sep; 10():19-24. PubMed ID: 27668172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges for implementing next-generation sequencing-based genome diagnostics: it's also the people, not just the machines.
    Veltman JA; Cuppen E; Vrijenhoek T
    Per Med; 2013 Jul; 10(5):473-484. PubMed ID: 29758834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, Implementation and Assessment of Molecular Diagnostics by Next Generation Sequencing in Personalized Treatment of Cancer: Experience of a Public Reference Healthcare Hospital.
    Simarro J; Murria R; Pérez-Simó G; Llop M; Mancheño N; Ramos D; Juan I; Barragán E; Laiz B; Cases E; Ansótegui E; Gómez-Codina J; Aparicio J; Salvador C; Juan Ó; Palanca S
    Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31426418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advance of next-generation sequencing in patients with lung cancer.
    Qiu T; Zhi X; Ren S
    Expert Rev Mol Diagn; 2023; 23(11):959-970. PubMed ID: 37750512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Opportunities and Challenges of Molecular Tagging Next-Generation Sequencing in Liquid Biopsy.
    De Luca G; Dono M
    Mol Diagn Ther; 2021 Sep; 25(5):537-547. PubMed ID: 34224097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Navigating the rapids: the development of regulated next-generation sequencing-based clinical trial assays and companion diagnostics.
    Pant S; Weiner R; Marton MJ
    Front Oncol; 2014; 4():78. PubMed ID: 24860780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prioritizing comparative effectiveness research for cancer diagnostics using a regional stakeholder approach.
    Klein G; Gold LS; Sullivan SD; Buist DS; Ramsey S; Kreizenbeck K; Snell K; Loggers ET; Gifford J; Watkins JB; Kessler L
    J Comp Eff Res; 2012 May; 1(3):241-55. PubMed ID: 23105966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
    Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
    Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Road to FAIR genomes: a gap analysis of NGS data generation and sharing in the Netherlands.
    Belien JAM; Kip AE; Swertz MA
    BMJ Open Sci; 2022; 6(1):e100268. PubMed ID: 35505836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre study.
    Bessi S; Pepe F; Russo G; Pisapia P; Ottaviantonio M; Biancalani F; Iaccarino A; Russo M; Biancalani M; Troncone G; Malapelle U
    J Clin Pathol; 2023 Mar; 76(3):206-210. PubMed ID: 35701144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis.
    van Amerongen RA; Retèl VP; Coupé VM; Nederlof PM; Vogel MJ; van Harten WH
    Ecancermedicalscience; 2016; 10():684. PubMed ID: 27899957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Can the EU Beating Cancer Plan Help in Tackling Lung Cancer, Colorectal Cancer, Breast Cancer and Melanoma?
    Horgan D; Baird AM; Middleton M; Mihaylova Z; Van Meerbeeck JP; Vogel-Claussen J; Van Schil PE; Malvehy J; Ascierto PA; Dube F; Zaiac M; Lal JA; Kamińska-Winciorek G; Donia M; André T; Kozaric M; Osterlund P; Dumitrascu DL; Bertolaccini L
    Healthcare (Basel); 2022 Aug; 10(9):. PubMed ID: 36141230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When should we order a next generation sequencing test in a patient with cancer?
    Colomer R; Mondejar R; Romero-Laorden N; Alfranca A; Sanchez-Madrid F; Quintela-Fandino M
    EClinicalMedicine; 2020 Aug; 25():100487. PubMed ID: 32775973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Development and Implementation of Good Laboratory Practice for NGS Based Targeted Panel on Solid Tumor FFPE Tissues in Diagnostics.
    Chougule A; Jagtap V; Nikam A; Kale S; Nambiar K; Bagayatkar P; Chandrani P; Kaushal R; Noronha V; Patil V; Banavali S; Prabhash K
    Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.